3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
4
OTHER_GOV
1
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Fallopian Tube Neoplasms
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Oesophagogastric Cancer
1
Neoplasms, Squamous Cell
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
2
pembrolizumab
1
lenvatinib
1
fluzoparib
1
apatinib
1
Surgical Procedures, Operative
1
Quality of Life
1
Paclitaxel
1
Nutritional Status
1
Neoadjuvant Therapy
1
Interviews as Topic
1
Indocyanine Green
1
Drug Therapy
1
Diagnostic Imaging
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Carcinoma, Ovarian Epithelial
×
Neoadjuvant Therapy
×
Clear all
NCT04515602
2020-08-27
FOCUS
Shanghai Gynecologic Oncology Group
Phase 3
Not yet recruiting
410 enrolled